Arkolith/Insider Trading/VLON/Form 4

Payne Joseph E

DirectorVallon Pharmaceuticals, Inc. (VLON) · full profile →Form 4 · filed May 27, 2021
Net Buying
Open-Market Buys
$72K
Open-Market Sells
$0
Net Open-Market Flow
$72K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 26, 2021Buy(P)7K$4.50$31K18K
May 25, 2021Buy(P)11K$3.85$41K11K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-073495) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML